Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jan Belohlavek

Showing results (61-70 of 137) with videos related to

Pageof 14
Sort By:
Critical Care Medicine|July 16, 2025
Cardiac Rhythm Conversions and the Outcome in Refractory Out-of-Hospital Cardiac Arrest: Extracorporeal Versus Conventional ResuscitationStepan Havranek, Jakub Neuhöfer, Michaela Vesela, et al.
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|January 9, 2022
A patient with pulmonary hypertension waiting for donor lungs during the pandemic: 194 days on extracorporeal life support including 143 days on pulmonary artery to left atrium shuntMartin Balik, Jan Rulisek, Marek Flaksa, et al.
Journal of Translational Medicine|May 22, 2013
Mild therapeutic hypothermia is superior to controlled normothermia for the maintenance of blood pressure and cerebral oxygenation, prevention of organ damage and suppression of oxidative stress after cardiac arrest in a porcine modelPetr Ostadal, Mikulas Mlcek, Andreas Kruger, et al.
ESC Heart Failure|July 23, 2020
The detrimental effect of COVID-19 nationwide quarantine on accelerometer-assessed physical activity of heart failure patientsTomas Vetrovsky, Tereza Frybova, Iulian Gant, et al.
Critical Care (London, England)|July 14, 2025
Cardiac index, SvO<sub>2</sub> or pCO<sub>2</sub> gap may determine benefit from ECMO in cardiogenic shock: post-hoc analysis of the multicenter, randomized ECMO-CS trialPetr Ostadal, Dagmar Vondrakova, Richard Rokyta, et al.
European Journal of Heart Failure|August 8, 2024
Extracorporeal membrane oxygenation in the therapy of cardiogenic shock: 1-year outcomes of the multicentre, randomized ECMO-CS trialPetr Ostadal, Richard Rokyta, Jiri Karasek, et al.
Resuscitation|May 17, 2025
The significance of possible non-occlusive mesenteric ischemia in relation to neurological outcomes in patients with refractory cardiac arrest - Secondary analysis of the Prague OHCA studyJana Smalcova, Jacky Suen, Michal Huptych, et al.
Critical Care (London, England)|April 16, 2024
Effect of intra-arrest transport, extracorporeal cardiopulmonary resuscitation and immediate invasive assessment in refractory out-of-hospital cardiac arrest: a long-term follow-up of the Prague OHCA trialDaniel Rob, Klaudia Farkasovska, Marketa Kreckova, et al.
European Heart Journal. Acute Cardiovascular Care|September 1, 2024
Do DanGer-SHOCK-like patients benefit from VA-ECMO treatment in infarct-related cardiogenic shock? results of an individual patient data meta-analysisUwe Zeymer, Anne Freund, Matthias Hochadel, et al.
Minerva Anestesiologica|April 13, 2017
Extracorporeal CO2 removal in critically ill patients: a systematic reviewFabio S Taccone, Maximilian V Malfertheiner, Fiorenza Ferrari, et al.
Pageof 14

Showing results (61-70 of 137) with videos related to

Sort By:
Pageof 14
Critical Care Medicine|July 16, 2025
Cardiac Rhythm Conversions and the Outcome in Refractory Out-of-Hospital Cardiac Arrest: Extracorporeal Versus Conventional ResuscitationStepan Havranek, Jakub Neuhöfer, Michaela Vesela, et al.
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|January 9, 2022
A patient with pulmonary hypertension waiting for donor lungs during the pandemic: 194 days on extracorporeal life support including 143 days on pulmonary artery to left atrium shuntMartin Balik, Jan Rulisek, Marek Flaksa, et al.
Journal of Translational Medicine|May 22, 2013
Mild therapeutic hypothermia is superior to controlled normothermia for the maintenance of blood pressure and cerebral oxygenation, prevention of organ damage and suppression of oxidative stress after cardiac arrest in a porcine modelPetr Ostadal, Mikulas Mlcek, Andreas Kruger, et al.
ESC Heart Failure|July 23, 2020
The detrimental effect of COVID-19 nationwide quarantine on accelerometer-assessed physical activity of heart failure patientsTomas Vetrovsky, Tereza Frybova, Iulian Gant, et al.
Critical Care (London, England)|July 14, 2025
Cardiac index, SvO<sub>2</sub> or pCO<sub>2</sub> gap may determine benefit from ECMO in cardiogenic shock: post-hoc analysis of the multicenter, randomized ECMO-CS trialPetr Ostadal, Dagmar Vondrakova, Richard Rokyta, et al.
European Journal of Heart Failure|August 8, 2024
Extracorporeal membrane oxygenation in the therapy of cardiogenic shock: 1-year outcomes of the multicentre, randomized ECMO-CS trialPetr Ostadal, Richard Rokyta, Jiri Karasek, et al.
Resuscitation|May 17, 2025
The significance of possible non-occlusive mesenteric ischemia in relation to neurological outcomes in patients with refractory cardiac arrest - Secondary analysis of the Prague OHCA studyJana Smalcova, Jacky Suen, Michal Huptych, et al.
Critical Care (London, England)|April 16, 2024
Effect of intra-arrest transport, extracorporeal cardiopulmonary resuscitation and immediate invasive assessment in refractory out-of-hospital cardiac arrest: a long-term follow-up of the Prague OHCA trialDaniel Rob, Klaudia Farkasovska, Marketa Kreckova, et al.
European Heart Journal. Acute Cardiovascular Care|September 1, 2024
Do DanGer-SHOCK-like patients benefit from VA-ECMO treatment in infarct-related cardiogenic shock? results of an individual patient data meta-analysisUwe Zeymer, Anne Freund, Matthias Hochadel, et al.
Minerva Anestesiologica|April 13, 2017
Extracorporeal CO2 removal in critically ill patients: a systematic reviewFabio S Taccone, Maximilian V Malfertheiner, Fiorenza Ferrari, et al.
Pageof 14